Quanterix Corp.
This article was originally published in Start Up
Executive Summary
Quanterix Corp. has applied fiber optic technology to immunodiagnostics to create a dramatic improvement in sensitivity based on single molecule counting. The company intends to use its platform to develop in vitro diagnostics for several clinical applications, beginning with prostate cancer and Alzheimer's disease.